Patient clinical characteristics
| . | n (%) . | |
|---|---|---|
| Patients enrolled | 39 | |
| Male/female | 23/16 | |
| Age | ||
| Mean ± SD | 58.9 ± 9.1 | |
| Range | 42-78 | |
| Weight | ||
| Mean ± SD | 55.8 ± 10.5 | |
| Range | 36-76 | |
| BMI | ||
| Mean ± SD | 21.8 ± 4.4 | |
| Range | 14.4-32.1 | |
| <18.5 | 9 (23.1) | |
| 18.5-25 | 25 (64.1) | |
| 25-30 | 5 (12.8) | |
| Weight loss before study entry | ||
| >10% | 5 (12.8) | |
| 5-10% | 9 (23.1) | |
| <5% | 3 (7.7) | |
| No weight loss | 22 (56.4) | |
| Tumor site | ||
| Head and neck | 17 (43.6) | |
| Lung | 8 (20.5) | |
| Ovary | 3 (7.7) | |
| Breast | 3 (7.7) | |
| Stomach | 2 (5.1) | |
| Pancreas | 2 (5.1) | |
| Liver | 2 (5.1) | |
| Kidney | 1 (2.6) | |
| Uterine sarcoma | 1 (2.6) | |
| Stage | ||
| IIIA | 1 (2.6) | |
| IV | 38 (97.4) | |
| ECOG PS | ||
| 0 | 2 (5.1) | |
| 1 | 27 (69.2) | |
| 2 | 10 (25.7) | |
| . | n (%) . | |
|---|---|---|
| Patients enrolled | 39 | |
| Male/female | 23/16 | |
| Age | ||
| Mean ± SD | 58.9 ± 9.1 | |
| Range | 42-78 | |
| Weight | ||
| Mean ± SD | 55.8 ± 10.5 | |
| Range | 36-76 | |
| BMI | ||
| Mean ± SD | 21.8 ± 4.4 | |
| Range | 14.4-32.1 | |
| <18.5 | 9 (23.1) | |
| 18.5-25 | 25 (64.1) | |
| 25-30 | 5 (12.8) | |
| Weight loss before study entry | ||
| >10% | 5 (12.8) | |
| 5-10% | 9 (23.1) | |
| <5% | 3 (7.7) | |
| No weight loss | 22 (56.4) | |
| Tumor site | ||
| Head and neck | 17 (43.6) | |
| Lung | 8 (20.5) | |
| Ovary | 3 (7.7) | |
| Breast | 3 (7.7) | |
| Stomach | 2 (5.1) | |
| Pancreas | 2 (5.1) | |
| Liver | 2 (5.1) | |
| Kidney | 1 (2.6) | |
| Uterine sarcoma | 1 (2.6) | |
| Stage | ||
| IIIA | 1 (2.6) | |
| IV | 38 (97.4) | |
| ECOG PS | ||
| 0 | 2 (5.1) | |
| 1 | 27 (69.2) | |
| 2 | 10 (25.7) | |
Abbreviation: ECOG PS, Eastern Cooperative Oncology Group performance status.